Latest News and Press Releases
Want to stay updated on the latest news?
-
Telenor legger frem resultater for fjerde kvartal 2025. Når: Fredag 6. februar 2026 kl 9.00. Presentasjonen vil holdes av finansdirektør Torbjørn Wist, under et midlertidig fravær av konsernsjef...
-
Join us for Telenor Group’s results for the fourth quarter 2025.When: Friday 6 February 2026, 09.00 CET / 08.00 UKT. The presentation will be held by Group CFO Torbjørn Wist, in the temporary...
-
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION,...
-
BIGBEN Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Article 223-16 du Règlement Général de l'Autorité des Marchés...
-
Announcement of Fixed Income Investor Meetings
-
Transgene renforce son comité scientifique avec l’arrivée d’Antoine Italiano et Ignacio Melero, deux experts renommés en immunothérapie du cancer
-
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
-
BIGBEN Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Article 223-16 du Règlement Général de l'Autorité des Marchés...
-
L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique Dans l'étude de phase 3 SHORE, l'amlitelimab en association avec des traitements topiques a atteint tous les critères...